In the early diagnosis of cardiac amyloidosis by point-of-care ultrasound (POCUS) in older patients with heart failure: towards a new standard of care?

Dobner S, Pilgrim T, Hagemeyer D, et al. Amyloid transthyretin cardiomyopathy in elderly patients with aortic stenosis undergoing transcatheter aortic valve implantation. J Am Heart Assoc 2023; 12: e030271.

Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583−596.

Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021; 42: 1554−1568.

Witteles RM, Bokhari S, Damy T, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail 2019; 7: 709−716.

Solla P, Cancelo P, López E, et al. Point-of-care ultrasonography in geriatric medicine: usefulness for approaching infectious endocarditis diagnosis. J Geriatr Cardiol 2022; 19: 1001−1002.

Maurer MS, Elliott P, Comenzo R, et al. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 2017; 135: 1357−1377.